|
PLEKHM2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
1.958880E-03 |
| Normal-vs-Stage3 |
3.06220049317574E-10 |
| Normal-vs-Stage4 |
1.07830000484199E-09 |
| Stage1-vs-Stage2 |
1.209580E-02 |
| Stage1-vs-Stage3 |
1.113220E-01 |
| Stage1-vs-Stage4 |
1.596590E-01 |
| Stage2-vs-Stage3 |
1.903820E-01 |
| Stage2-vs-Stage4 |
1.906410E-01 |
| Stage3-vs-Stage4 |
8.930800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.21964677141295E-15 |
| Normal-vs-AfricanAmerican |
1.75600001206533E-09 |
| Normal-vs-Asian |
5.47509999559992E-08 |
| Caucasian-vs-AfricanAmerican |
8.336300E-03 |
| Caucasian-vs-Asian |
8.826200E-02 |
| AfricanAmerican-vs-Asian |
6.005400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.00306438102871E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.595500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.084090E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
2.10276240864005E-13 |
| Normal-vs-Age(81-100Yrs) |
6.878800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.817600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.630400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.563200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.229210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.915400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.443600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.62836411021772E-12 |
| Normal-vs-Grade 2 |
5.55111512312578E-16 |
| Normal-vs-Grade 3 |
8.2021944791677E-11 |
| Normal-vs-Grade 4 |
6.61593002604377E-12 |
| Grade 1-vs-Grade 2 |
1.497730E-03 |
| Grade 1-vs-Grade 3 |
1.75319999999868E-05 |
| Grade 1-vs-Grade 4 |
1.057200E-03 |
| Grade 2-vs-Grade 3 |
2.618100E-02 |
| Grade 2-vs-Grade 4 |
6.897800E-01 |
| Grade 3-vs-Grade 4 |
3.178300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.6251444634463E-12 |
| Normal-vs-ccB subtype |
4.98709995522262E-09 |
| ccA subtype-vs-ccB subtype |
1.013570E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.2199355948801E-12 |
| Normal-vs-N1 |
7.235500E-04 |
| N0-vs-N1 |
2.707600E-01 |
|
|
